ES2067324T3 - Procedimiento para la obtencion de microparticulas que contienen principio activo, a partir de polimeros degradables por hidrolisis. - Google Patents

Procedimiento para la obtencion de microparticulas que contienen principio activo, a partir de polimeros degradables por hidrolisis.

Info

Publication number
ES2067324T3
ES2067324T3 ES92901683T ES92901683T ES2067324T3 ES 2067324 T3 ES2067324 T3 ES 2067324T3 ES 92901683 T ES92901683 T ES 92901683T ES 92901683 T ES92901683 T ES 92901683T ES 2067324 T3 ES2067324 T3 ES 2067324T3
Authority
ES
Spain
Prior art keywords
pct
containing active
hydrolysis
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92901683T
Other languages
English (en)
Inventor
Heike Biskup
Elke Gorissen
Hannelore Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanol Schwarz GmbH
UCB Pharma GmbH
Original Assignee
Sanol Schwarz GmbH
Schwarz Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Schwarz GmbH, Schwarz Pharma AG filed Critical Sanol Schwarz GmbH
Application granted granted Critical
Publication of ES2067324T3 publication Critical patent/ES2067324T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer
    • Y10T428/2987—Addition polymer from unsaturated monomers only

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polyamides (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

LA INVENCION CONCIERNE A UN PROCEDIMIENTO, PARA LA OBTENCION DE MICROPARTICULAS CONTENIENDO SUSTANCIAS ACTIVAS, A BASE DE POLIMEROS HIDROLITICAMENTE DEGRADABLES, ESPECIALMENTE COPOLIMEROS, POR MEDIO DE GASES FLUIDOS, CON UNA DISTRIBUCION UNIFORME DEL TAMAÑO DE PARTICULA, Y POR ADICION DE AMINOACIDOS BIOLOGICAMENTE TOLERABLES. LAS MICROPARTICULAS OBTENIDAS POR ESTE PROCEDIMIENTO, SON UTILIZABLES COMO MEDICAMENTOS PARA PERSONAS Y ANIMALES.
ES92901683T 1990-12-22 1991-12-18 Procedimiento para la obtencion de microparticulas que contienen principio activo, a partir de polimeros degradables por hidrolisis. Expired - Lifetime ES2067324T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4041563A DE4041563A1 (de) 1990-12-22 1990-12-22 Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren

Publications (1)

Publication Number Publication Date
ES2067324T3 true ES2067324T3 (es) 1995-03-16

Family

ID=6421280

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92901683T Expired - Lifetime ES2067324T3 (es) 1990-12-22 1991-12-18 Procedimiento para la obtencion de microparticulas que contienen principio activo, a partir de polimeros degradables por hidrolisis.

Country Status (15)

Country Link
US (1) US5424076A (es)
EP (1) EP0563176B1 (es)
JP (1) JP3496153B2 (es)
KR (1) KR0162105B1 (es)
AT (1) ATE116542T1 (es)
CA (1) CA2098814C (es)
DE (2) DE4041563A1 (es)
DK (1) DK0563176T3 (es)
ES (1) ES2067324T3 (es)
FI (1) FI102811B1 (es)
GR (1) GR3015623T3 (es)
HU (1) HU217817B (es)
IE (1) IE65915B1 (es)
PT (1) PT99892B (es)
WO (1) WO1992011000A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
US6169763B1 (en) 1995-06-29 2001-01-02 Qualcomm Inc. Characterizing a communication system using frame aligned test signals
FR2753639B1 (fr) * 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
US5766637A (en) * 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
DE19711393C1 (de) * 1997-03-19 1998-08-13 Fraunhofer Ges Forschung Verfahren zum Mikroverkapseln von Partikeln
FR2776516B1 (fr) * 1998-03-25 2001-05-25 Pharma Biotech Compositions presentant une liberation prolongee et leur procede de preparation
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
FR2762318B1 (fr) * 1997-04-18 1999-09-17 Pharma Biotech Compositions presentant une liberation prolongee et leur procede de preparation
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
GB9810559D0 (en) * 1998-05-15 1998-07-15 Bradford Particle Design Ltd Method and apparatus for particle formation
GB9915975D0 (en) 1999-07-07 1999-09-08 Bradford Particle Design Ltd Method for the formation of particles
US6680284B1 (en) 1999-07-13 2004-01-20 Degussa Ag Method for producing powdery particle-reduced formulations with the aid of compressed gases
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
FR2811913B1 (fr) * 2000-07-19 2003-09-19 Separex Sa Procede d'encapsulation sous forme de micro-capsules de fines particules solides
US6521258B1 (en) * 2000-09-08 2003-02-18 Ferro Corporation Polymer matrices prepared by supercritical fluid processing techniques
US6579532B1 (en) * 2000-09-08 2003-06-17 Ferro Corporation Orthopedic mixtures prepared by supercritical fluid processing techniques
GB0027357D0 (en) * 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
US6966990B2 (en) * 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
US20040185110A1 (en) * 2002-11-08 2004-09-23 Ronald Harland Formulations of low solubility bioactive agents and processes for making the same
CA2524773C (en) 2003-05-08 2014-04-08 Nektar Therapeutics Uk Ltd Particulate coformulations of active substances with excipients
US7507823B2 (en) * 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
EP1757361A1 (en) 2005-08-23 2007-02-28 Feyecon Development & Implementation B.V. Process for the preparation of encapsulates through precipitation
EP2476412B1 (en) * 2006-10-11 2014-03-19 Crititech, Inc. Apparatus for precipitation of small medicament particles into use containers
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
ATE521337T1 (de) * 2007-07-18 2011-09-15 Feyecon Bv Verfahren zur herstellung einer pharmazeutischen co-kristall-zusammensetzung
US20110027172A1 (en) * 2007-12-10 2011-02-03 Zhuang Wang Drug delivery system for pharmaceuticals and radiation
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
DE3218151A1 (de) * 1982-05-14 1983-11-17 Akzo Gmbh, 5600 Wuppertal Mikroporoese, pulverfoermige polylactide und verfahren zu deren herstellung
CA1241246A (en) * 1983-07-21 1988-08-30 Salomon Hakim Surgically-implantable device susceptible of noninvasive magnetic adjustment
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
HU192982B (en) * 1984-04-28 1987-08-28 Allatorvostudomanyi Egyetem Process for producing synergetic pharmaceutical compositions containing thiamulin and antibacterial and antiprotozoal organic acids
DE3428372A1 (de) * 1984-08-01 1986-02-13 Hoechst Ag, 6230 Frankfurt Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen
DE3701625A1 (de) * 1987-01-21 1988-08-04 Boehringer Ingelheim Kg Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe
DE3738228A1 (de) * 1987-11-11 1989-05-24 Hoechst Ag Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln
DE3744329A1 (de) * 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
US5271945A (en) * 1988-07-05 1993-12-21 Takeda Chemical Industries, Ltd. Sustained release microcapsule for water soluble drug
JP2827287B2 (ja) * 1988-07-05 1998-11-25 武田薬品工業株式会社 水溶性薬物含有徐放型マイクロカプセル
JPH0739339B2 (ja) * 1989-05-01 1995-05-01 アルカーメス コントロールド セラピューティクス，インコーポレイテッド 生物活性を有する分子の小粒子の製造方法
DE3917617A1 (de) * 1989-05-31 1990-12-06 Boehringer Ingelheim Kg Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung
US5232707A (en) * 1989-07-10 1993-08-03 Syntex (U.S.A.) Inc. Solvent extraction process
CA2020755A1 (en) * 1989-07-10 1991-01-11 David M. Lokensgard Solvent extraction process
GB8928250D0 (en) * 1989-12-14 1990-02-21 Erba Carlo Spa Use of supercritical fluids to obtain porous sponges of biodegradable polymers

Also Published As

Publication number Publication date
CA2098814C (en) 1999-05-11
JPH06504531A (ja) 1994-05-26
PT99892B (pt) 1999-06-30
HU217817B (hu) 2000-04-28
JP3496153B2 (ja) 2004-02-09
KR930701985A (ko) 1993-09-08
GR3015623T3 (en) 1995-06-30
KR0162105B1 (ko) 1998-12-01
ATE116542T1 (de) 1995-01-15
IE914313A1 (en) 1992-07-01
US5424076A (en) 1995-06-13
DE59104172D1 (de) 1995-02-16
DE4041563A1 (de) 1992-06-25
CA2098814A1 (en) 1992-06-23
FI102811B (fi) 1999-02-26
EP0563176B1 (de) 1995-01-04
DK0563176T3 (da) 1995-03-06
PT99892A (pt) 1992-12-31
FI932761A (fi) 1993-06-16
HUT63954A (en) 1993-11-29
EP0563176A1 (en) 1993-10-06
HU9301812D0 (en) 1993-09-28
FI932761A0 (fi) 1993-06-16
WO1992011000A1 (de) 1992-07-09
FI102811B1 (fi) 1999-02-26
IE65915B1 (en) 1995-11-29

Similar Documents

Publication Publication Date Title
ES2067324T3 (es) Procedimiento para la obtencion de microparticulas que contienen principio activo, a partir de polimeros degradables por hidrolisis.
DE69520036T2 (de) Verfahren zur herstellung von festen pharmazeutischen dosierungsformen hydrophobischen substanzen
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
ATE179886T1 (de) Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung
DE69521406T2 (de) Apparat und verfahren zur herstellung fester formen mit gesteuerter freisetzung des wirkstoffs
KR950700764A (ko) 신규 생활성 코팅재, 그 제조방법 및 용도
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
GEP20022707B (en) Biodegrading Macromers for the Controlled Release of Biologically Active Substances
DE69508192T2 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
ID21682A (id) Turunan-turunan pirolo [3,4-d] pirimidinon dan penggunaannya sebagai obat-obatan
ATE367087T1 (de) Formulierungen zur behandlung von krankheiten und verfahren unter deren verwendung
DE69519685T2 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
ATE173578T1 (de) Implantierbare formkörper zur verabreichung von wirkstoffen an pflanzen
DE60112777D1 (de) Beschichtete medizinische geräte und verfahren zur sterilisation
DE50206912D1 (de) Verfahren zur kontinuierlichen herstellung und beschichtung von selbstklebemassen auf basis von sbc mit mindestens einem pharmazeutischen wirkstoff
ATE196404T1 (de) Implantierbare vorrichtung zur verabreichung von wirkstoffen an pflanzen
DE69306390D1 (de) Zusammenfassung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselbe
DE69623652D1 (de) Formulierung zur peptidfreisetzung
ATE499069T1 (de) Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563176

Country of ref document: ES